MedTrace Logo

Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer

NCT00019201 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-04-29

No results posted yet for this study

Summary

RATIONALE: Fluorescent bronchoscopy, when used in combination with conventional white light bronchoscopy, may improve the ability to detect early lung cancer.

PURPOSE: A pilot study to evaluate fluorescent light bronchoscopy plus conventional bronchoscopy as a tool for screening and detecting lung cancer in persons with completely resected head and neck cancer or successfully treated early-stage lung cancer.

Conditions

Interventions

OTHER

cytology specimen collection procedure

OTHER

immunohistochemistry staining method

OTHER

sputum cytology

PROCEDURE

bronchoscopic and lung imaging studies

PROCEDURE

bronchoscopy

PROCEDURE

comparison of screening methods

PROCEDURE

endoscopic biopsy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • J. Michael Hamilton, MD · National Cancer Institute (NCI)

Study Design

Purpose
SCREENING

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00019201 on ClinicalTrials.gov